Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #182386 on Anavex Life Sciences Corp (AVXL)
nidan7500
02/20/19 12:52 PM
#182389 RE: drv17 #182386
Federico Goodsaid,3Harald Hampel,1 Mohammad Afshar2, Frédéric Parmentier2, Coralie Williams2, Adrien Etcheto2, Christopher U Missling4 1Department of Neurology, Sorbonne University, Paris, France, 2Ariana Pharma, Paris, France, 3Regulatory Pathfnders LLC, San Francisco, CA, 4Anavex Life Sciences Corp., New York, NY “Longitudinal 148-Week Extension Study for ANAVEX®2-73 Phase 2a Alzheimer’s Disease Demonstrates Maintained Activities of Daily Living Score (ADCS-ADL) and Reduced Cognitive Decline (MMSE) for Patient Cohort on Higher Drug Concentration and Confrms Role of Patient Selection Biomarkers